Tech Company Financing Transactions
Bonti Funding Round
City Hill Ventures and private investors invested in a $15.5 million Series C venture round for Bonti. The round closed on 1/24/2018.
Transaction Overview
Company Name
Announced On
1/24/2018
Transaction Type
Venture Equity
Amount
$15,500,000
Round
Series C
Investors
City Hill Ventures (Lead Investor) (Jonathan Lim)
Proceeds Purpose
Capital from the round will be used to continue developing EB-001, a unique botulinum neurotoxin, for its targeted therapeutic and aesthetic indications with significant addressable unmet needs in patients.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4921 Birch St. 120
Newport Beach, CA 92660
USA
Newport Beach, CA 92660
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Bonti, based in Newport Beach, California, is a rapidly emerging biotechnology company founded by world class neurotoxin experts with proven success at Allergan, one of the Fortune 500 fastest growing pharma companies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Fauad Hasan
Chief Medical Officer
Susan Abushakra
Chief Operating Officer
Wajdie Ahmad
Co-Founder
Mike Jarpe
VP - Regulatory Affairs
James Stonecypher
Browse more venture capital transactions:
Prev: 1/24/2018: Cognovi Labs venture capital transaction
Next: 1/24/2018: Unravel Data venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs